ANDA 201944, held by Tris Pharma Inc. Potassium Chloride.
As of Nov 15, 2026, ANDA 201944 (Potassium Chloride), held by Tris Pharma Inc, was first approved by FDA on Mar 4, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 4, 2016 | Original application | Approved | None posted |
| Potassium Chloride8MEQ · capsule, extended release;oral | Potassium Chloride | Discontinued |
| Potassium Chloride10MEQ · capsule, extended release;oral | Potassium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
